Publication Date:
2015-07-28
Description:
Background Malignancy is known to be associated with increased mortality rate for patients with Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN). However, risk factors contributing to poor prognosis of SJS/TEN patients with malignancies remain undefined. Objectives To explore the potential involvement of malignancy and its related factors contributing to the poor outcome of SJS/TEN, we conducted a retrospective study. Methods In total 517 SJS/TEN patients enrolled, 47 of patients sustaining various types of malignancies were analyzed for numerous malignancy-related factors, including cancer types, clinical stages, and chemotherapies given or not before the onset of SJS/TEN. Results We found that the mortality rate of SJS/TEN patients with malignancies is higher than that of patients without malignancies (31.91%, 15/47 and 8.51%, 40/470, respectively) (p 〈0.001). The use of phenytoin was significantly higher in the malignancy group. The existence of hepatocellular carcinoma (80%, 4/5; p〈0.0001; OR=43) and colorectal cancer (66.67%, 2/3; p=0.0217; OR=21.5) significantly increased the death rate of SJS/TEN patients, whereas lung cancer and urothelial carcinoma did not. Patients who received ongoing or recent chemotherapy show increased mortality as compared to those without chemotherapy (p=0.0217; OR=4.95). Furthermore, among 47 SJS/TEN patients with malignancies, lower serum albumin, hemoglobulin, and platelet count were detected in the deceased patients in comparison to the survived patients before the onset of SJS/TEN. Conclusion Our results suggest that several factors related to malignancies, such as specific cancer types, chemotherapy and malnutrition may contribute to poor prognosis of patients with malignancies developing SJS/TEN. This article is protected by copyright. All rights reserved.
Print ISSN:
0007-0963
Electronic ISSN:
1365-2133
Topics:
Medicine
Permalink